» Articles » PMID: 27621621

The Effect of ZnO Nanoparticles on Liver Function in Rats

Overview
Publisher Dove Medical Press
Specialty Biotechnology
Date 2016 Sep 14
PMID 27621621
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Zinc oxide (ZnO) is widely incorporated as a food additive in animal diets. In order to optimize the beneficial effects of ZnO and minimize any resultant environmental pollution, ZnO nanoparticles are often used for delivery of the zinc. However, the possible toxic effects of ZnO nanoparticles, including effects on cytochrome P450 (CYP450) enzymes, have not been evaluated. In this study, we investigated the effect of ZnO nanoparticles, in doses used in animal feeds, on CYP450 enzymes, liver and intestinal enzymes, liver and kidney histopathology, and hematologic indices in rats. We found that liver and kidney injury occurred when the concentrations of ZnO nanoparticles in feed were 300-600 mg/kg. Also, liver mRNA expression for constitutive androstane receptor was suppressed and mRNA expression for pregnane X receptor was induced when feed containing ZnO nanoparticles was given at a concentration of 600 mg/kg. Although the expression of mRNA for CYP 2C11 and 3A2 enzymes was induced by ZnO nanoparticles, the activities of CYP 2C11 and 3A2 were suppressed. While liver CYP 1A2 mRNA expression was suppressed, CYP 1A2 activity remained unchanged at all ZnO nanoparticle doses. Therefore, it has been concluded that ZnO nanoparticles, in the doses customarily added to animal feed, changed the indices of hematology and blood chemistry, altered the expression and activity of hepatic CYP enzymes, and induced pathological changes in liver and kidney tissues of rats. These findings suggest that greater attention needs to be paid to the toxic effects of ZnO nanoparticles in animal feed, with the possibility that the doses of ZnO should be reduced.

Citing Articles

Histological Assessment of Systemic Toxicity Induced by Zinc oxide Nanoparticles and the Prophylactic Potency of Ascorbate in Albino Rats.

Osman A, Afify S, Frag A, Alghandour S J Microsc Ultrastruct. 2025; 12(4):177-192.

PMID: 39811592 PMC: 11729027. DOI: 10.4103/jmau.jmau_68_22.


Synthesis, characterization, and evaluation of copper-doped zinc oxide nanoparticles anticancer effects: in vitro and in vivo experiments.

Ghaznavi H, Hajinezhad M, Hesari Z, Shirvaliloo M, Sargazi S, Shahraki S BMC Cancer. 2025; 25(1):37.

PMID: 39780079 PMC: 11707944. DOI: 10.1186/s12885-024-13398-w.


Electrophysiological and biochemical effect of zinc oxide nanoparticles on heart functions of male Wistar rats.

Hussein A, Moatamed E, El-Desoky M, El Khayat Z Sci Rep. 2024; 14(1):15416.

PMID: 38965270 PMC: 11224369. DOI: 10.1038/s41598-024-65189-9.


Toxicity and Hepatoprotective Effects of ZnO Nanoparticles on Normal and High-Fat Diet-Fed Rat Livers: Mechanism of Action.

Mirzaei F, Abbasi E, Mirzaei A, Fayazi Hosseini N, Naseri N, Khodadadi I Biol Trace Elem Res. 2024; 203(1):199-217.

PMID: 38441796 DOI: 10.1007/s12011-024-04108-5.


Biosynthesis and biocompatibility evaluation of zinc oxide nanoparticles prepared using Priestia megaterium bacteria.

Ashour M, Abd-Elhalim B Sci Rep. 2024; 14(1):4147.

PMID: 38378738 PMC: 10879496. DOI: 10.1038/s41598-024-54460-8.


References
1.
Rao M, Biju B, Ansar A, Mujeeb S, Ramesh M, Srinivas N . 'Open access' generic method for continuous determination of major human CYP450 probe substrates/metabolites and its application in drug metabolism studies. Xenobiotica. 2004; 33(12):1233-45. DOI: 10.1080/00498250310001636877. View

2.
Renton K, Knickle L . Regulation of hepatic cytochrome P-450 during infectious disease. Can J Physiol Pharmacol. 1990; 68(6):777-81. DOI: 10.1139/y90-119. View

3.
Goossens J, de Bock L, Osselaere A, Verbrugghe E, Devreese M, Boussery K . The mycotoxin T-2 inhibits hepatic cytochrome P4503A activity in pigs. Food Chem Toxicol. 2013; 57:54-6. DOI: 10.1016/j.fct.2013.03.009. View

4.
MANNERING G, Deloria L, Abbott V . Role of xanthine oxidase in the interferon-mediated depression of the hepatic cytochrome P-450 system in mice. Cancer Res. 1988; 48(8):2107-12. View

5.
Li K, Chen Y, Zhang W, Pu Z, Jiang L, Chen Y . Surface interactions affect the toxicity of engineered metal oxide nanoparticles toward Paramecium. Chem Res Toxicol. 2012; 25(8):1675-81. DOI: 10.1021/tx300151y. View